These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 29241782)

  • 21. Botulinum toxin type A for neuropathic itch.
    Wallengren J; Bartosik J
    Br J Dermatol; 2010 Aug; 163(2):424-6. PubMed ID: 20346021
    [No Abstract]   [Full Text] [Related]  

  • 22. What does the future hold for botulinum neuromodulators in facial aesthetics?
    Sattler G
    J Eur Acad Dermatol Venereol; 2012 Mar; 26(3):394-5. PubMed ID: 21492251
    [No Abstract]   [Full Text] [Related]  

  • 23. Botulinum toxin-A for the treatment of Raynaud syndrome.
    Smith L; Polsky D; Franks AG
    Arch Dermatol; 2012 Apr; 148(4):426-8. PubMed ID: 22508867
    [No Abstract]   [Full Text] [Related]  

  • 24. Are there any drawbacks to smoothing out lines and wrinkles with Botox injections?
    Johns Hopkins Med Lett Health After 50; 2014 Jul; 26(6):7. PubMed ID: 25178125
    [No Abstract]   [Full Text] [Related]  

  • 25. Regarding the treatment of dynamic nasal tip ptosis with botulinum toxin A.
    Ghavami A; Janis JE; Guyuron B
    Plast Reconstr Surg; 2006 Jul; 118(1):263-4. PubMed ID: 16816709
    [No Abstract]   [Full Text] [Related]  

  • 26. Botulinum toxin treatment for oropharyngeal dysphagia due to tetanus.
    Restivo DA; Marchese-Ragona R
    J Neurol; 2006 Mar; 253(3):388-9. PubMed ID: 16382373
    [No Abstract]   [Full Text] [Related]  

  • 27. The increasing popularity of Botox injections.
    Zaidi Z
    J Pak Med Assoc; 2007 Feb; 57(2):53-5. PubMed ID: 17370783
    [No Abstract]   [Full Text] [Related]  

  • 28. Botulinum toxin type A in the management of a neuropathic foot ulcer.
    Alsharqi A; Curley R; Winhoven S
    Clin Exp Dermatol; 2011 Dec; 36(8):915-6. PubMed ID: 21623883
    [No Abstract]   [Full Text] [Related]  

  • 29. Asymmetry and Maldistribution of Polyacrylamide Hydrogel Filler in the Infraorbital Area Successfully Managed With Botulinum Toxin A Treatment.
    Lee SK; Kim HS
    Dermatol Surg; 2016 Dec; 42(12):1395-1397. PubMed ID: 27399939
    [No Abstract]   [Full Text] [Related]  

  • 30. Botulinum toxin treatment for upper airway collapse resulting from temporomandibular joint dislocation due to jaw-opening dystonia.
    Yoshida K; Iizuka T
    Cranio; 2006 Jul; 24(3):217-22. PubMed ID: 16933464
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Neuromodulators: available agents, physiology, and anatomy.
    Nettar K; Maas C
    Facial Plast Surg; 2011 Dec; 27(6):517-22. PubMed ID: 22205524
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hyperhidrosis of face and scalp: repeated successful treatment with botulinum toxin type A.
    Komericki P; Ardjomand N
    Indian J Dermatol Venereol Leprol; 2012; 78(2):201-2. PubMed ID: 22421660
    [No Abstract]   [Full Text] [Related]  

  • 33. Myofascial pain.
    Malcmacher L
    Dent Today; 2013 Dec; 32(12):16. PubMed ID: 24494450
    [No Abstract]   [Full Text] [Related]  

  • 34. Successful treatment of vulvodynia with botulinum toxin A.
    Tieu KD; MacGregor JL
    Arch Dermatol; 2011 Feb; 147(2):251-2. PubMed ID: 21339463
    [No Abstract]   [Full Text] [Related]  

  • 35. Should we stop using botulinum neurotoxin type a in patients with neurogenic detrusor overactivity after development of secondary resistance?
    Pistolesi D; Giannarini G; Stampacchia G; Selli C
    Eur Urol; 2011 Oct; 60(4):872-3. PubMed ID: 21802198
    [No Abstract]   [Full Text] [Related]  

  • 36. [Treatment of wrinkles with botulinum toxin].
    Lanzl I; Merté RL
    Ophthalmologe; 2007 Sep; 104(9):777-82. PubMed ID: 17823803
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Use of botulinum toxin A for treatment of myofascial pain and dysfunction.
    Fallah HM; Currimbhoy S
    J Oral Maxillofac Surg; 2012 May; 70(5):1243-5. PubMed ID: 22538024
    [No Abstract]   [Full Text] [Related]  

  • 38. Use of mirror dystonia as guidance for injection of botulinum toxin in writing dysfunction.
    Singer C; Papapetropoulos S; Vela L
    J Neurol Neurosurg Psychiatry; 2005 Nov; 76(11):1608-9. PubMed ID: 16227568
    [No Abstract]   [Full Text] [Related]  

  • 39. Botulinum toxin (Botox, Dysport, and Myobloc): pharmacology 101.
    Wynn RL
    Gen Dent; 2011; 59(2):88-90. PubMed ID: 21903516
    [No Abstract]   [Full Text] [Related]  

  • 40. [Facial palsy sequel and botulinum toxin].
    Benichou L; Labbe D; Le Louarn C; Guerreschi P
    Ann Chir Plast Esthet; 2015 Oct; 60(5):377-92. PubMed ID: 26432177
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.